| Meraj Siddiqui, MD | |
|
1215 Sidney St, Batesville, AR 72501 | |
| (870) 262-6155 | |
| (870) 262-6187 |
| Full Name | Meraj Siddiqui |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 30 Years |
| Location | 1215 Sidney St, Batesville, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114973922 | NPI | - | NPPES |
| 5N520 | Other | AR | BLUE CROSS OF AR |
| Facility Name | Location | Facility Type |
|---|---|---|
| White River Medical Center | Batesville, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pain Treatment Centers Of America Pllc | 2769608819 | 51 |
News Archive
Researchers will be exploring whether a new, very low cost, one-a-day combined 'polypill' could reduce the risk of heart attacks, strokes and other cardiovascular problems across the world, in a major new international trial that launches today.
University of Hawai'i Cancer Center researchers have discovered germline BAP1 mutations are associated with a novel cancer syndrome characterized by malignant mesothelioma, uveal melanoma, cutaneous melanoma and atypical melanocytic tumors. Germline mutations are hereditary gene defects that are present in every cell.
Drug overdose is now the leading cause of death for individuals under the age of 50, as the opioid epidemic continues unabated. One reason is that the majority of the estimated 2.4 million Americans with opioid use disorder aren't getting evidence-based treatment, including medications to treat opioid addiction.
Indevus Pharmaceuticals, Inc. has announced that it has entered into a co-promotion and licensing agreement with PLIVA d.d. through its specialty branded subsidiary, Odyssey Pharmaceuticals Inc., for the U.S. commercialization of SANCTURA™ (trospium chloride), under review by the U.S. Food and Drug Administration (FDA) as a treatment for overactive bladder.
› Verified 4 days ago
| Entity Name | White River Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760410229 PECOS PAC ID: 0143134270 Enrollment ID: O20031203000615 |
News Archive
Researchers will be exploring whether a new, very low cost, one-a-day combined 'polypill' could reduce the risk of heart attacks, strokes and other cardiovascular problems across the world, in a major new international trial that launches today.
University of Hawai'i Cancer Center researchers have discovered germline BAP1 mutations are associated with a novel cancer syndrome characterized by malignant mesothelioma, uveal melanoma, cutaneous melanoma and atypical melanocytic tumors. Germline mutations are hereditary gene defects that are present in every cell.
Drug overdose is now the leading cause of death for individuals under the age of 50, as the opioid epidemic continues unabated. One reason is that the majority of the estimated 2.4 million Americans with opioid use disorder aren't getting evidence-based treatment, including medications to treat opioid addiction.
Indevus Pharmaceuticals, Inc. has announced that it has entered into a co-promotion and licensing agreement with PLIVA d.d. through its specialty branded subsidiary, Odyssey Pharmaceuticals Inc., for the U.S. commercialization of SANCTURA™ (trospium chloride), under review by the U.S. Food and Drug Administration (FDA) as a treatment for overactive bladder.
› Verified 4 days ago
| Entity Name | White River Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558447599 PECOS PAC ID: 0143134270 Enrollment ID: O20080206000654 |
News Archive
Researchers will be exploring whether a new, very low cost, one-a-day combined 'polypill' could reduce the risk of heart attacks, strokes and other cardiovascular problems across the world, in a major new international trial that launches today.
University of Hawai'i Cancer Center researchers have discovered germline BAP1 mutations are associated with a novel cancer syndrome characterized by malignant mesothelioma, uveal melanoma, cutaneous melanoma and atypical melanocytic tumors. Germline mutations are hereditary gene defects that are present in every cell.
Drug overdose is now the leading cause of death for individuals under the age of 50, as the opioid epidemic continues unabated. One reason is that the majority of the estimated 2.4 million Americans with opioid use disorder aren't getting evidence-based treatment, including medications to treat opioid addiction.
Indevus Pharmaceuticals, Inc. has announced that it has entered into a co-promotion and licensing agreement with PLIVA d.d. through its specialty branded subsidiary, Odyssey Pharmaceuticals Inc., for the U.S. commercialization of SANCTURA™ (trospium chloride), under review by the U.S. Food and Drug Administration (FDA) as a treatment for overactive bladder.
› Verified 4 days ago
| Entity Name | Pain Treatment Centers Of America Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841619731 PECOS PAC ID: 2769608819 Enrollment ID: O20140725000128 |
News Archive
Researchers will be exploring whether a new, very low cost, one-a-day combined 'polypill' could reduce the risk of heart attacks, strokes and other cardiovascular problems across the world, in a major new international trial that launches today.
University of Hawai'i Cancer Center researchers have discovered germline BAP1 mutations are associated with a novel cancer syndrome characterized by malignant mesothelioma, uveal melanoma, cutaneous melanoma and atypical melanocytic tumors. Germline mutations are hereditary gene defects that are present in every cell.
Drug overdose is now the leading cause of death for individuals under the age of 50, as the opioid epidemic continues unabated. One reason is that the majority of the estimated 2.4 million Americans with opioid use disorder aren't getting evidence-based treatment, including medications to treat opioid addiction.
Indevus Pharmaceuticals, Inc. has announced that it has entered into a co-promotion and licensing agreement with PLIVA d.d. through its specialty branded subsidiary, Odyssey Pharmaceuticals Inc., for the U.S. commercialization of SANCTURA™ (trospium chloride), under review by the U.S. Food and Drug Administration (FDA) as a treatment for overactive bladder.
› Verified 4 days ago
| Entity Name | Ptcoa Home Infusion Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235723313 PECOS PAC ID: 7810354644 Enrollment ID: O20230608002801 |
News Archive
Researchers will be exploring whether a new, very low cost, one-a-day combined 'polypill' could reduce the risk of heart attacks, strokes and other cardiovascular problems across the world, in a major new international trial that launches today.
University of Hawai'i Cancer Center researchers have discovered germline BAP1 mutations are associated with a novel cancer syndrome characterized by malignant mesothelioma, uveal melanoma, cutaneous melanoma and atypical melanocytic tumors. Germline mutations are hereditary gene defects that are present in every cell.
Drug overdose is now the leading cause of death for individuals under the age of 50, as the opioid epidemic continues unabated. One reason is that the majority of the estimated 2.4 million Americans with opioid use disorder aren't getting evidence-based treatment, including medications to treat opioid addiction.
Indevus Pharmaceuticals, Inc. has announced that it has entered into a co-promotion and licensing agreement with PLIVA d.d. through its specialty branded subsidiary, Odyssey Pharmaceuticals Inc., for the U.S. commercialization of SANCTURA™ (trospium chloride), under review by the U.S. Food and Drug Administration (FDA) as a treatment for overactive bladder.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Meraj Siddiqui, MD 125 Dennison Hts, Batesville, AR 72501-8936 Ph: (870) 834-4499 | Meraj Siddiqui, MD 1215 Sidney St, Batesville, AR 72501 Ph: (870) 262-6155 |
News Archive
Researchers will be exploring whether a new, very low cost, one-a-day combined 'polypill' could reduce the risk of heart attacks, strokes and other cardiovascular problems across the world, in a major new international trial that launches today.
University of Hawai'i Cancer Center researchers have discovered germline BAP1 mutations are associated with a novel cancer syndrome characterized by malignant mesothelioma, uveal melanoma, cutaneous melanoma and atypical melanocytic tumors. Germline mutations are hereditary gene defects that are present in every cell.
Drug overdose is now the leading cause of death for individuals under the age of 50, as the opioid epidemic continues unabated. One reason is that the majority of the estimated 2.4 million Americans with opioid use disorder aren't getting evidence-based treatment, including medications to treat opioid addiction.
Indevus Pharmaceuticals, Inc. has announced that it has entered into a co-promotion and licensing agreement with PLIVA d.d. through its specialty branded subsidiary, Odyssey Pharmaceuticals Inc., for the U.S. commercialization of SANCTURA™ (trospium chloride), under review by the U.S. Food and Drug Administration (FDA) as a treatment for overactive bladder.
› Verified 4 days ago
John R Larson, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1215 Sidney St, Suite 203, Batesville, AR 72501 Phone: 870-262-6155 Fax: 870-262-6152 | |
Miss Srishti Srivastava, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1700 Harrison St Ste T, Batesville, AR 72501 Phone: 870-262-6155 Fax: 870-262-6152 | |
Dr. Carol J. Mccourt, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1700 Harrison St, Suite T, Batesville, AR 72501 Phone: 870-262-6155 Fax: 870-262-6512 | |
Christopher Steel Jr., MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1710 Harrison St, Batesville, AR 72501 Phone: 870-262-1200 | |
Wyatt Lydolph, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1710 Harrison St, Batesville, AR 72501 Phone: 870-262-1200 |